FDA Approves New Dosing Guidelines for Afrezza Inhaled Insulin
MannKind (MNKD) receives FDA approval for updated Afrezza dosing recommendations, making it easier for patients to switch from insulin injections to inhaled insulin therapy.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
MannKind (MNKD) receives FDA approval for updated Afrezza dosing recommendations, making it easier for patients to switch from insulin injections to inhaled insulin therapy.
SkyWater Technology stock surges 6% as IonQ announces $35/share acquisition creating first vertically integrated quantum platform company worth $1.8 billion.
Baker Hughes reports 11% profit increase in Q4 2025 as gas technology equipment demand offsets weakness in oilfield services business.
Samsung Electronics will begin producing HBM4 memory chips for Nvidia next month, intensifying competition with Micron and SK Hynix in the booming AI chip market.
Trump administration invests $1.6 billion in USA Rare Earth company, securing 10% stake to boost domestic production of critical minerals essential for technology and defense.
Merck has walked away from negotiations to acquire Revolution Medicines after failing to agree on price for the promising cancer drug developer valued around $30 billion.